H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Biogen Inc (NASDAQ:BIIB) on Tuesday, setting a price target of... By Deena Beasley (Reuters) - U.S. health experts this week will ...

Oppenheimer analyst Jay Olson maintained a Buy rating on Biogen (NASDAQ:BIIB) on Wednesday, setting a price target of $300, which ...

Biogen secures rights to commercialize zorevunersen outside North America, while Stoke leads global development and retains U.S. rights. Stoke receives $165 million upfront, up to $385 million in ...

Biogen has refueled its R&D engine, paying Stoke Therapeutics $165 million upfront for ex-U.S. rights to a phase 3-ready molecule that could become the first disease-modifying treatment for Dravet ...

He has not appeared in the arena for several years.This appearance in the arena will definitely cause a lot of blood feuds, not to mention that Ye Chuan and Grasshopper are already aware of it, even ...

Zorevunersen is intended for treating Dravet syndrome. Credit: Maks_lab/Shutterstock. Biogen has entered a collaboration with Stoke Therapeutics to develop and and commercialise zorevunersen to treat ...

CAMBRIDGE, Mass., March 11, 2025 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) – announced the initiation of dosing in the global clinical study, TRANSCEND. The Phase 3 study will evaluate the ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Biogen has finalised a $900 million payment to settle a whistleblower lawsuit claiming that it paid kickbacks to US doctors to prescribe its multiple sclerosis drugs.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Recent rumours that Biogen was about to acquired by Samsung proved unfounded, but it turns out a deal has been in preparation. The South Korean firm just agreed to buy Biogen out of their ...

Commissions do not affect our editors' opinions or evaluations. Today’s average price of gas in the U.S. is $3.08 per gallon, unchanged from yesterday, down $0.01 from last week and down $0.08 ...